Related references
Note: Only part of the references are listed.被撤回的出版物: Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications (Retracted article. See vol. 109, pg. 455, 2014)
Gati A. Goel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Estrogen receptor-β signaling modulates epithelial barrier function
Mirjam Looijer-van Langen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Chemopreventive Effect of ERβ-Selective Agonist on Intestinal Tumorigenesis in ApcMin/+ Mice
Veronique Giroux et al.
MOLECULAR CARCINOGENESIS (2011)
Estrogen Receptor β Induces Antiinflammatory and Antitumorigenic Networks in Colon Cancer Cells
Karin Edvardsson et al.
MOLECULAR ENDOCRINOLOGY (2011)
Enhanced Induction of Mucin-Depleted Foci in Estrogen Receptor β Knockout Mice
Diana Saleiro et al.
CANCER PREVENTION RESEARCH (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Yi Li et al.
GUT (2010)
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer
S. Danese et al.
ONCOGENE (2010)
Efficacy and Safety of a Selective Estrogen Receptor β Agonist, ERB-041, in Patients With Rheumatoid Arthritis: A 12-Week, Randomized, Placebo-Controlled, Phase II Study
Jorge A. Roman-Blas et al.
ARTHRITIS CARE & RESEARCH (2010)
Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients
Andrzej Szkaradkiewicz et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
ERB-041, a selective ERβ agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-κB activation
Wang Xiu-li et al.
MOLECULAR IMMUNOLOGY (2009)
Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease
Sunanda V. Kane et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
High frequency of early colorectal cancer in inflammatory bowel disease
M. W. M. D. Lutgens et al.
GUT (2008)
Oestrogen and the colon: potential mechanisms for cancer prevention
Rory Kennelly et al.
LANCET ONCOLOGY (2008)
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
C Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Expression of vitamin D receptor and 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant human colon
D Matusiak et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate
R Suzuki et al.
CANCER SCIENCE (2004)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
SH Itzkowitz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease
DC Harnish et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Mucins and mucin binding proteins in colorectal cancer
JC Byrd et al.
CANCER AND METASTASIS REVIEWS (2004)
Evaluation of an estrogen receptor-β agonist in animal models of human disease
HA Harris et al.
ENDOCRINOLOGY (2003)
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease
P Munkholm
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
PA Konstantinopoulos et al.
EUROPEAN JOURNAL OF CANCER (2003)
A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate
T Tanaka et al.
CANCER SCIENCE (2003)
Colorectal cancer in mice genetically deficient in the mucin Muc2
A Velcich et al.
SCIENCE (2002)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action
SC Hewitt et al.
BREAST CANCER RESEARCH (2000)